Evidence map›Paper›PMID 37361660›Full record

ArticleClinical case reports2023

Pulmonary miliary sarcoidosis masquerading the reactivation of tuberculosis 30 years later.

Takashi Okuma, Reimi Mizushima, Yukihisa Takeda, Kazutoshi Toriyama, Yusuke Watanabe, Hiroyuki Nakamura, Kazutetsu Aoshiba

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takashi OkumaDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.
Reimi MizushimaDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.
Yukihisa TakedaDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.
Kazutoshi ToriyamaDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.
Yusuke WatanabeDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.ORCID https://orcid.org/0000-0001-8182-069X
Hiroyuki NakamuraDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.
Kazutetsu AoshibaDepartment of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan.ORCID https://orcid.org/0000-0002-9490-9754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Sarcoidosis may occur after treatment with pulmonary tuberculosis and requires differential diagnosis from tuberculosis reactivation. Miliary sarcoidosis should be promptly differentiated from miliary tuberculosis associated with high mortality. Abstract: Clinical, histological, and radiological similarities between sarcoidosis and tuberculosis render differential diagnosis challenging. The association between these two diseases has long been discussed, although the coexistence or subsequent occurrence of tuberculosis and sarcoidosis is rare. We report a case of miliary sarcoidosis that developed 30 years after tuberculous pleurisy treatment. Sarcoidosis may occur after treatment with pulmonary tuberculosis and requires differential diagnosis from tuberculosis reactivation. Although miliary sarcoidosis is uncommon, it should be promptly differentiated from miliary tuberculosis associated with high mortality. This study reignites the debate on the causal association between tuberculosis and sarcoidosis.

Indexed as

granulomahigh‐resolution computed tomographymiliary tuberculosissarcoidosis

Identifiers

PMID37361660
PMCPMC10290199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.